471 related articles for article (PubMed ID: 34497604)
1. Revelation of Potent Epitopes Present in Unannotated ORF Antigens of SARS-CoV-2 for Epitope-Based Polyvalent Vaccine Design Using Immunoinformatics Approach.
Uttamrao PP; Sathyaseelan C; Patro LPP; Rathinavelan T
Front Immunol; 2021; 12():692937. PubMed ID: 34497604
[TBL] [Abstract][Full Text] [Related]
2. A vaccine built from potential immunogenic pieces derived from the SARS-CoV-2 spike glycoprotein: A computational approximation.
Marchan J
J Immunol Methods; 2022 Mar; 502():113216. PubMed ID: 35007561
[TBL] [Abstract][Full Text] [Related]
3. Identification of SARS-CoV-2 Nucleocapsid and Spike T-Cell Epitopes for Assessing T-Cell Immunity.
Lee E; Sandgren K; Duette G; Stylianou VV; Khanna R; Eden JS; Blyth E; Gottlieb D; Cunningham AL; Palmer S
J Virol; 2021 Feb; 95(6):. PubMed ID: 33443088
[TBL] [Abstract][Full Text] [Related]
4. Landscape and selection of vaccine epitopes in SARS-CoV-2.
Smith CC; Olsen KS; Gentry KM; Sambade M; Beck W; Garness J; Entwistle S; Willis C; Vensko S; Woods A; Fini M; Carpenter B; Routh E; Kodysh J; O'Donnell T; Haber C; Heiss K; Stadler V; Garrison E; Sandor AM; Ting JPY; Weiss J; Krajewski K; Grant OC; Woods RJ; Heise M; Vincent BG; Rubinsteyn A
Genome Med; 2021 Jun; 13(1):101. PubMed ID: 34127050
[TBL] [Abstract][Full Text] [Related]
5. A reverse vaccinology and immunoinformatics approach for designing a multiepitope vaccine against SARS-CoV-2.
Jahangirian E; Jamal GA; Nouroozi M; Mohammadpour A
Immunogenetics; 2021 Dec; 73(6):459-477. PubMed ID: 34542663
[TBL] [Abstract][Full Text] [Related]
6. Designing of a next generation multiepitope based vaccine (MEV) against SARS-COV-2: Immunoinformatics and in silico approaches.
Tahir Ul Qamar M; Rehman A; Tusleem K; Ashfaq UA; Qasim M; Zhu X; Fatima I; Shahid F; Chen LL
PLoS One; 2020; 15(12):e0244176. PubMed ID: 33351863
[TBL] [Abstract][Full Text] [Related]
7. Immunoinformatics-guided design of an epitope-based vaccine against severe acute respiratory syndrome coronavirus 2 spike glycoprotein.
Rakib A; Sami SA; Mimi NJ; Chowdhury MM; Eva TA; Nainu F; Paul A; Shahriar A; Tareq AM; Emon NU; Chakraborty S; Shil S; Mily SJ; Ben Hadda T; Almalki FA; Emran TB
Comput Biol Med; 2020 Sep; 124():103967. PubMed ID: 32828069
[TBL] [Abstract][Full Text] [Related]
8. Exploring the out of sight antigens of SARS-CoV-2 to design a candidate multi-epitope vaccine by utilizing immunoinformatics approaches.
Safavi A; Kefayat A; Mahdevar E; Abiri A; Ghahremani F
Vaccine; 2020 Nov; 38(48):7612-7628. PubMed ID: 33082015
[TBL] [Abstract][Full Text] [Related]
9. Immunodominant linear B cell epitopes in the spike and membrane proteins of SARS-CoV-2 identified by immunoinformatics prediction and immunoassay.
Polyiam K; Phoolcharoen W; Butkhot N; Srisaowakarn C; Thitithanyanont A; Auewarakul P; Hoonsuwan T; Ruengjitchatchawalya M; Mekvichitsaeng P; Roshorm YM
Sci Rep; 2021 Oct; 11(1):20383. PubMed ID: 34650130
[TBL] [Abstract][Full Text] [Related]
10. Immunoinformatics mapping of potential epitopes in SARS-CoV-2 structural proteins.
Devi YD; Goswami HB; Konwar S; Doley C; Dolley A; Devi A; Chongtham C; Dowerah D; Biswa V; Jamir L; Kumar A; Satapathy SS; Ray SK; Deka RC; Doley R; Mandal M; Das S; Singh CS; Borah PP; Nath P; Namsa ND
PLoS One; 2021; 16(11):e0258645. PubMed ID: 34780495
[TBL] [Abstract][Full Text] [Related]
11. Preclinical evaluation of a synthetic peptide vaccine against SARS-CoV-2 inducing multiepitopic and cross-reactive humoral neutralizing and cellular CD4 and CD8 responses.
Aparicio B; Casares N; Egea J; Ruiz M; Llopiz D; Maestro S; Olagüe C; González-Aseguinolaza G; Smerdou C; López-Díaz de Cerio A; Inogés S; Prósper F; Yuste JR; Carmona-Torre F; Reina G; Lasarte JJ; Sarobe P
Emerg Microbes Infect; 2021 Dec; 10(1):1931-1946. PubMed ID: 34538222
[TBL] [Abstract][Full Text] [Related]
12. An in silico deep learning approach to multi-epitope vaccine design: a SARS-CoV-2 case study.
Yang Z; Bogdan P; Nazarian S
Sci Rep; 2021 Feb; 11(1):3238. PubMed ID: 33547334
[TBL] [Abstract][Full Text] [Related]
13. Cross-Recognition of SARS-CoV-2 B-Cell Epitopes with Other Betacoronavirus Nucleoproteins.
Tajuelo A; López-Siles M; Más V; Pérez-Romero P; Aguado JM; Briz V; McConnell MJ; Martín-Galiano AJ; López D
Int J Mol Sci; 2022 Mar; 23(6):. PubMed ID: 35328398
[TBL] [Abstract][Full Text] [Related]
14. Identification of Highly Conserved SARS-CoV-2 Antigenic Epitopes with Wide Coverage Using Reverse Vaccinology Approach.
Hisham Y; Ashhab Y; Hwang SH; Kim DE
Viruses; 2021 Apr; 13(5):. PubMed ID: 33925069
[TBL] [Abstract][Full Text] [Related]
15. Design of a Recombinant Multivalent Epitope Vaccine Based on SARS-CoV-2 and Its Variants in Immunoinformatics Approaches.
Yu M; Zhu Y; Li Y; Chen Z; Li Z; Wang J; Li Z; Zhang F; Ding J
Front Immunol; 2022; 13():884433. PubMed ID: 35603198
[TBL] [Abstract][Full Text] [Related]
16. Preliminary Identification of Potential Vaccine Targets for the COVID-19 Coronavirus (SARS-CoV-2) Based on SARS-CoV Immunological Studies.
Ahmed SF; Quadeer AA; McKay MR
Viruses; 2020 Feb; 12(3):. PubMed ID: 32106567
[TBL] [Abstract][Full Text] [Related]
17. Limited Recognition of Highly Conserved Regions of SARS-CoV-2.
Swaminathan S; Lineburg KE; Ambalathingal GR; Crooks P; Grant EJ; Mohan SV; Raju J; Panikkar A; Le Texier L; Tong ZWM; Chew KY; Neller MA; Short KR; Gowda H; Gras S; Khanna R; Smith C
Microbiol Spectr; 2022 Feb; 10(1):e0278021. PubMed ID: 35196796
[TBL] [Abstract][Full Text] [Related]
18. Identification of Unique Peptides for SARS-CoV-2 Diagnostics and Vaccine Development by an
Kesarwani V; Gupta R; Vetukuri RR; Kushwaha SK; Gandhi S
Front Immunol; 2021; 12():725240. PubMed ID: 34630400
[TBL] [Abstract][Full Text] [Related]
19. Design of an epitope-based peptide vaccine against the SARS-CoV-2: a vaccine-informatics approach.
Alam A; Khan A; Imam N; Siddiqui MF; Waseem M; Malik MZ; Ishrat R
Brief Bioinform; 2021 Mar; 22(2):1309-1323. PubMed ID: 33285567
[TBL] [Abstract][Full Text] [Related]
20. Predicted Epitope Abundance Supports Vaccine-Induced Cytotoxic Protection Against SARS-CoV-2 Variants of Concern.
Martín-Galiano AJ; Díez-Fuertes F; McConnell MJ; López D
Front Immunol; 2021; 12():732693. PubMed ID: 34899692
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
